Characteristics of patients younger than 20 years of age
. | No. eval . | Japanese . | No. eval. . | White American . | P . |
|---|---|---|---|---|---|
| Disease type, no (%) | .04 | ||||
| AML | 156 | 66 (42) | 144 | 78 (54) | |
| ALL | 67 (43) | 42 (29) | |||
| CML | 23 (15) | 24 (17) | |||
| Donor-patient sex match, no (%) | .80 | ||||
| M-M | 144 | 37 (26) | 142 | 42 (30) | |
| M-F | 39 (27) | 32 (22) | |||
| F-M | 43 (30) | 43 (30) | |||
| F-F | 25 (17) | 25 (28) | |||
| Donor-patient CMV status, no (%) | .01 | ||||
| Both negative | 76 | 25 (33) | 143 | 73 (51) | |
| At least 1 positive | 51 (67) | 67 (47) | |||
| Inconclusive/not tested | 0 | 3 (2) | |||
| Conditioning regimen, no (%) | < .001 | ||||
| BuCy ± other | 156 | 49 (32) | 144 | 60 (42) | |
| TBICy ± other | 64 (41) | 37 (26) | |||
| TBI ± other | 13 (8) | 36 (25) | |||
| Other | 30 (19) | 11 (7) | |||
| Patient age, y, median (range) | 156 | 16 (1-20) | 144 | 13 (0-20) | .001 |
| 0-10 | 42 (27) | 55 (38) | .04 | ||
| Older than 10 | 114 (73) | 89 (62) | NA | ||
| WBC count at diagnosis, × 109/L | 143 | 23 (1-541) | 138 | 28 (0-923) | .30 |
| Karnofsky score, 90%-100%, no (%) | ND | 144 | 127 (88) | NA | |
| Year of treatment | 156 | 94 (90-99) | 144 | 94 (90-99) | |
| 1990-1994 | 81 (52) | 73 (51) | .93 | ||
| 1995-1999 | 75 (48) | 71 (49) | .83 | ||
| Time from diagnosis to treatment, mo | 154 | 7.1 (1.4-37.9) | 143 | 3.8 (1.2-62.0) | < .001 |
| Follow-up time among patients who survived, mo | 109 | 71 (8-138) | 101 | 37 (3-127) | < .001 |
. | No. eval . | Japanese . | No. eval. . | White American . | P . |
|---|---|---|---|---|---|
| Disease type, no (%) | .04 | ||||
| AML | 156 | 66 (42) | 144 | 78 (54) | |
| ALL | 67 (43) | 42 (29) | |||
| CML | 23 (15) | 24 (17) | |||
| Donor-patient sex match, no (%) | .80 | ||||
| M-M | 144 | 37 (26) | 142 | 42 (30) | |
| M-F | 39 (27) | 32 (22) | |||
| F-M | 43 (30) | 43 (30) | |||
| F-F | 25 (17) | 25 (28) | |||
| Donor-patient CMV status, no (%) | .01 | ||||
| Both negative | 76 | 25 (33) | 143 | 73 (51) | |
| At least 1 positive | 51 (67) | 67 (47) | |||
| Inconclusive/not tested | 0 | 3 (2) | |||
| Conditioning regimen, no (%) | < .001 | ||||
| BuCy ± other | 156 | 49 (32) | 144 | 60 (42) | |
| TBICy ± other | 64 (41) | 37 (26) | |||
| TBI ± other | 13 (8) | 36 (25) | |||
| Other | 30 (19) | 11 (7) | |||
| Patient age, y, median (range) | 156 | 16 (1-20) | 144 | 13 (0-20) | .001 |
| 0-10 | 42 (27) | 55 (38) | .04 | ||
| Older than 10 | 114 (73) | 89 (62) | NA | ||
| WBC count at diagnosis, × 109/L | 143 | 23 (1-541) | 138 | 28 (0-923) | .30 |
| Karnofsky score, 90%-100%, no (%) | ND | 144 | 127 (88) | NA | |
| Year of treatment | 156 | 94 (90-99) | 144 | 94 (90-99) | |
| 1990-1994 | 81 (52) | 73 (51) | .93 | ||
| 1995-1999 | 75 (48) | 71 (49) | .83 | ||
| Time from diagnosis to treatment, mo | 154 | 7.1 (1.4-37.9) | 143 | 3.8 (1.2-62.0) | < .001 |
| Follow-up time among patients who survived, mo | 109 | 71 (8-138) | 101 | 37 (3-127) | < .001 |
ND indicates no data; NA, not applicable.